Marlan Walker
Chief Executive Officer bij THERAPEUTICSMD, INC.
Vermogen: 143 274 $ op 31-03-2024
Profiel
Marlan D.
Walker is currently the Chief Executive Officer at TherapeuticsMD, Inc. He previously worked as the Intellectual Property Counsel at Medicis Pharmaceutical Corp.
from 2011 to 2012.
Mr. Walker has an undergraduate degree and a graduate degree from Brigham Young University.
He also holds a graduate degree from George Washington University Law School, which he obtained in 2005.
Additionally, he has a graduate degree from Sandra Day O'Connor College of Law, which he received in 2004.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
THERAPEUTICSMD, INC.
0.59% | 07-12-2023 | 62 565 ( 0.59% ) | 143 274 $ | 31-03-2024 |
Actieve functies van Marlan Walker
Bedrijven | Functie | Begin |
---|---|---|
THERAPEUTICSMD, INC. | Chief Executive Officer | 30-12-2022 |
Eerdere bekende functies van Marlan Walker
Bedrijven | Functie | Einde |
---|---|---|
MEDICIS PHARMACEUTICAL CORP | Corporate Officer/Principal | 01-12-2012 |
Opleiding van Marlan Walker
Brigham Young University | Graduate Degree |
George Washington University Law School | Graduate Degree |
Sandra Day Oconnor College of Law | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
THERAPEUTICSMD, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Medicis Pharmaceutical Corp.
Medicis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Medicis Pharmaceutical Corp. develops and markets pharmaceutical products for dermatological usages. It offers a broad range of products addressing various conditions or aesthetic improvements, including facial wrinkles, glabellar lines, acne, fungal infections, rosacea, hyperpigmentation, photoaging, psoriasis, seborrheic dermatitis and cosmesis. The company was founded on July 28, 1988 and is headquartered in Phoenix, AZ. | Health Technology |